Effects of Endocrine-Disrupting Chemicals on Obesity and Diabetes

被引:1
|
作者
Cander, Soner [1 ]
Yetkin, Ilhan [2 ]
机构
[1] Bursa Uludag Univ, Dept Endocrinol & Metab, Bursa, Turkiye
[2] Gazi Univ, Dept Endocrinol & Metab, Ankara, Turkiye
来源
ENDOCRINOLOGY RESEARCH AND PRACTICE | 2023年 / 27卷 / 04期
关键词
Diabetes; EDC; endocrine-disrupting chemicals; metabolic syndrome; obesity; BISPHENOL-A; ORGANOTIN COMPOUNDS; METABOLIC SYNDROME; ADIPOSE-TISSUE; HUMAN HEALTH; STEM-CELLS; TRIBUTYLTIN; INSULIN; EXPOSURE; ADIPOGENESIS;
D O I
10.5152/erp.2023.23309
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The increasing incidence of obesity and type 2 diabetes mellitus (T2DM) is a global problem. Although the obesity epidemic is mostly associated with a lack of physical activity and diet, several chemicals have been demonstrated to have a potential role in its pathophysiological mechanisms. An accumulating volume of evidence indicates that a subclass of endocrine-disrupting chemicals (EDCs) can impair hormonally regulated metabolic processes, particularly in the case of exposure early in life when the defense mechanisms of the human body are yet to be fully developed. These chemicals are called "obesogenic EDCs" and might cause some people to gain weight despite their attempts to increase physical activity and limit calorie intake. Similarly, background exposure to some environmental EDCs has been associated with diabetes and impaired glucose metabolism. Certain widespread EDCs, including pesticides, dioxins, and bisphenol A, in animal models may change beta function and insulin resistance. These EDCs, which may accumulate in adipose tissue and cause a pro-inflammatory response, can also be found at measurable levels in human blood and can either imitate or block some hormonal reactions. In this review, we evaluate EDCs in relation to obesity and T2DM in light of the current literature.
引用
收藏
页码:233 / 240
页数:8
相关论文
共 50 条
  • [1] Obesity and endocrine-disrupting chemicals
    Amato, Angelica Amorim
    Wheeler, Hailey Brit
    Blumberg, Bruce
    ENDOCRINE CONNECTIONS, 2021, 10 (02) : R87 - R105
  • [2] Epigenetic Mechanisms of Endocrine-Disrupting Chemicals in Obesity
    Nettore, Immacolata Cristina
    Franchini, Fabiana
    Palatucci, Giuseppe
    Macchia, Paolo Emidio
    Ungaro, Paola
    BIOMEDICINES, 2021, 9 (11)
  • [3] Endocrine-disrupting chemicals and their effects on puberty
    Lopez-Rodriguez, David
    Franssen, Delphine
    Heger, Sabine
    Parent, Anne-Simone
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 35 (05)
  • [4] Effects of Endocrine-Disrupting Chemicals on the Ovary
    Patel, Shreya
    Zhou, Changqing
    Rattan, Saniya
    Flaws, Jodi A.
    BIOLOGY OF REPRODUCTION, 2015, 93 (01)
  • [5] Endocrine-Disrupting Chemicals
    Gore, Andrea C.
    JAMA INTERNAL MEDICINE, 2016, 176 (11) : 1705 - 1706
  • [6] Endocrine-disrupting chemicals
    Kiess, Wieland
    Haeusler, Gabriele
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 35 (05)
  • [7] Endocrine-disrupting chemicals
    Bertram, Michael G.
    Gore, Andrea C.
    Tyler, Charles R.
    Brodin, Tomas
    CURRENT BIOLOGY, 2022, 32 (13)
  • [8] Endocrine-Disrupting Chemicals
    Friedrich, M. J.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (15): : 1578 - 1578
  • [9] Obesity, Diabetes, and Associated Costs of Exposure to Endocrine-Disrupting Chemicals in the European Union
    Legler, Juliette
    Fletcher, Tony
    Govarts, Eva
    Porta, Miquel
    Blumberg, Bruce
    Heindel, Jerrold J.
    Trasande, Leonardo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (04): : 1278 - 1288
  • [10] Endocrine-disrupting chemicals and obesity development in humans: A review
    Tang-Peronard, J. L.
    Andersen, H. R.
    Jensen, T. K.
    Heitmann, B. L.
    OBESITY REVIEWS, 2011, 12 (08) : 622 - 636